Back to Search Start Over

Potential of the miR-200 Family as a Target for Developing Anti-Cancer Therapeutics

Authors :
Hyein Jo
Kyeonghee Shim
Dooil Jeoung
Source :
International Journal of Molecular Sciences, Vol 23, Iss 11, p 5881 (2022)
Publication Year :
2022
Publisher :
MDPI AG, 2022.

Abstract

MicroRNAs (miRNAs) are small non-coding RNAs (18–24 nucleotides) that play significant roles in cell proliferation, development, invasion, cancer development, cancer progression, and anti-cancer drug resistance. miRNAs target multiple genes and play diverse roles. miRNAs can bind to the 3′UTR of target genes and inhibit translation or promote the degradation of target genes. miR-200 family miRNAs mostly act as tumor suppressors and are commonly decreased in cancer. The miR-200 family has been reported as a valuable diagnostic and prognostic marker. This review discusses the clinical value of the miR-200 family, focusing on the role of the miR-200 family in the development of cancer and anti-cancer drug resistance. This review also provides an overview of the factors that regulate the expression of the miR-200 family, targets of miR-200 family miRNAs, and the mechanism of anti-cancer drug resistance regulated by the miR-200 family.

Details

Language :
English
ISSN :
14220067 and 16616596
Volume :
23
Issue :
11
Database :
Directory of Open Access Journals
Journal :
International Journal of Molecular Sciences
Publication Type :
Academic Journal
Accession number :
edsdoj.fe808726e3284c948c590330cc58f825
Document Type :
article
Full Text :
https://doi.org/10.3390/ijms23115881